最佳Rheumatology播客 (2024)

1
Artificial Intelligence (AI) and Rheumatology 35:18

3d ago35:18

35:18

In this talking Rheumatology spotlight podcast on artificial intellgence and Rheumatology I (Dr Pip Watson, BSR DLE) talk to Dr Nick Fuggle and Dr Samantha Cooray. Our conversation covers everything from what we mean by AI and machine learning to current and future applications of AI in Rheumatology plus should we be scared and what might the futur…

1
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis 10:32

6d ago10:32

10:32

Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care and treatment for GCA patients, including increasing disease awareness, faster referral to specialised care, better ac…

1
Ep 17. CAREERS - The role of a Pharmacist in Rheumatology 23:39

18d ago23:39

23:39

In this episode, Dr Anastasia Madenidou and Rebecca Heaton talk about the important and exciting role of a pharmacist working in a rheumatology team. Please note this careers episode has been previously released through another BSR podcast series.由British Society for Rheumatology

1
Ep 36. Osteoporosis 27:28

1M ago27:28

27:28

In this Talking Rheumatology spotlight pod on Osteoporosis, Dr Pip Watson talks to Prof Zoe Paskins about osteoporosis- they cover everything from fracture risk to calcium intake, anabolic drugs, promoting adherence to treatment and treatment pauses. For more info on talking to patients about osteoporosis and shared decision making check out https:…

1
Ep 35. Difficult to treat Rheumatoid Arthritis (RA) 36:55

1M ago36:55

36:55

In this pod Dr Pip Watson is joined by Prof Maya Buch, they discuss everything you need to know around difficult to treat RA, including tips on managing patients in this group and treatment adherance.由British Society for Rheumatology

1
Karen Schreiber, Ian Giles, and Angela Tincani on the Pregnancy and Rheumatic Diseases Series 34:33

1M ago34:33

34:33

Dr Karen Schreiber, Professor Ian Giles, and Professor Angela Tincani discuss the Series on Pregnancy and Rheumatic Diseases, including the use of DMARDs during pregnancy, study design and conduct, and outcomes for children born to mothers with rheumatic diseases. Read the Series: https://thelancet.com/series/pregnancy-rheumatic-diseases?dgcid=buzz…

1
EP 16. CAREERS - The role of a First Contact Practitioner (FCP) 23:25

1M ago23:25

23:25

Do you know your First Contact Practitioner from you physiotherapist or osteopath? In this pod Will Gregory (Consultant Physio and BSR Vice President) talks to Sarah Golding (Physio and FCP) about all things FCP including requirements for the role, how it works and links with secondary care Rheumatology. This is essential listening for those workin…

1
Ep 46. Patient involvement in Rheumatology research 21:25

2M ago21:25

21:25

Peter Boyd and Ingrid de Groot join Dr. Latika Gupta to explore the value of patient involvement in Rheumatology research. Reflecting on their lived experience, Peter and Ingrid discuss their proudest moments, and identify areas in the patient and physician partnership that they hope to improve in the future. Thanks for listening to Talking Rheumat…

1
Ep 34. Rheumatoid arthritis 25:13

2M ago25:13

25:13

In this episode, Dr Stephanie Gall talks to Prof Chris Edwards about how to approach the management of Rheumatoid arthritis (RA) and the importance of personalising care. A wide ranging discussion covering the role of corticosteroids, impact of inflammation on cognition and ILD.由British Society for Rheumatology

1
Treating EGPA With Drs. Leonard Calabrese and Anisha Dua 16:01

2M ago16:01

16:01

In this podcast, expert clinicians will discuss the latest evidence regarding EGPA therapy, as well as current guideline recommendations. https://www.healio.com/cme/mededtalks/rheumatology/20240617/3-treating-egpa

1
EGPA Differential Diagnosis With Drs. Leonard Calabrese and Michael Putman 16:01

2M ago16:01

16:01

In this podcast, expert clinicians discuss the differential diagnosis of EGPA, reviewing the utility of various diagnostic modalities that can differentiate EGPA from other hypereosinophilic diseases or ANCA-associated vasculitides. https://www.healio.com/cme/mededtalks/rheumatology/20240617/2-egpa-differential-diagnosis…

1
EGPA Burden and Clinical Manifestations With Drs. Leonard Calabrese and Adam Brown 15:23

2M ago15:23

15:23

In this podcast, expert clinicians discuss the spectrum of potential EGPA clinical manifestations. https://www.healio.com/cme/mededtalks/rheumatology/20240617/1-egpa-burden-and-clinical-manifestations

1
Ep 33. Immunology for the rheumatologist 41:15

2M ago41:15

41:15

In this episode, Dr Roz Benson chats with Dr Frances Hall and Dr Ondrej Suchanek about immunology for the rheumatologist. They discuss the adaptive and innate immune system, testing for autoimmune diseases, and how we can talk to our patients about these conditions.由British Society for Rheumatology

1
Dr Maria Tektonidou on cardiovascular risk factors in systemic lupus erythematosus 11:20

3M ago11:20

11:20

Dr Maria Tektonidou discusses the results of a cross-sectional analysis of international data on cardiovascular risk factors in systemic lupus erythematosus. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com…

1
Ep 45. Community awareness of childhood arthritis in the UK 9:34

3M ago9:34

9:34

Recorded at #BSR24, Richard P Beesley joins Dr Ai Lyn Tan to discuss his recent article, which measured the level of community awareness in the UK that children and young people can develop arthritis. Listen now to hear about what you can do to help raise awareness, and why this is so important. You can read this article [https://doi.org/10.1093/ra…

1
Ep 32. Shoulder tendinopathies in inflammatory conditions 27:45

3M ago27:45

27:45

In this episode, Dave Pilbury talks to Mr Muthu Jeyam about the shoulder, with a focus on surgical interventions: when and how should we intervene and how well does it work?由British Society for Rheumatology

1
Ep 44. Neuropsychiatric symptoms in systemic autoimmune rheumatic diseases 12:34

3M ago12:34

12:34

In this fascinating episode recorded at #BSR24, Dr Melanie Sloan joins Prof Ernest Choy to discuss the latest results from the INSPIRE study, which seeks to understand neuropsychiatric symptom prevalence and impact in people with systemic autoimmune rheumatic diseases (SARDs). Dr Melanie Sloan is a researcher in the Department of Public Health and …

1
Rosemary Hollick on improving services for adults with rare autoimmune rheumatic diseases 16:17

3M ago16:17

16:17

Dr Rosemary Hollick, University of Aberdeen, discusses a mixed-methods study on key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/…

1
BONUS CASE. Myositis 35:47

4M ago35:47

35:47

In this episode Dr Ashley Elliot speaks with Professor Hector Chinoy and Dr Alex Oldroyd. They discuss a complex case of myositis highlighting common diagnostic challenges, role of investigations and approach to treatment. A great overview in a field which is constantly evolving!由British Society for Rheumatology

1
Ep 31. IgG4 related disease 31:03

4M ago31:03

31:03

In this episode, Dr Yik Man talks to Prof David D'Cruz about IgG4 related disease, including an approach to management and some tricky cases.由British Society for Rheumatology

1
Ep 30. Juvenile idiopathic arthritis 20:53

4M ago20:53

20:53

In this episode, Dr Chris Wincup talks to Dr Rachel Tattersall about all things JIA including differences between JIA and adult onset IA, transition, disease activity scoring and biologics. This podcast is likely to suit adult rheumatologists - we're planning a future episode for our paediatric audience so watch this space!…

1
Ep 15. GUIDELINES - BSR Sjögren disease guideline 2024 14:24

5M ago14:24

14:24

BSR has published an update to the Sjögren disease guideline, expanded to include paediatric and adolescent patients for the first time. Join guideline working group Chair, Liz Price, members Coziana Ciurtin and Benjamin Fisher, and expert by experience member, Bridget Crampton, in a roundtable discussion hosted by Dr Marwan Bukhari. Please note Dr…

1
Ep. 43 The metaverse: a new frontier for rheumatology 11:16

5M ago11:16

11:16

Dr Jason E Liebowitz joins Dr Marwan Bukhari to discuss the metaverse and how the field of rheumatology can utilise virtual and augmented reality to improve the lives of patients. Listen now to hear about the current technological developments and what this means for future clinical practice! You can read this article [https://doi.org/10.1093/rheum…

1
Ep 14. CAREERS - Getting involved in Guidelines 19:48

5M ago19:48

19:48

This podcast gives an opportunity to hear from Dr Caroline Cotton, Lara Chapman and Dr Mark Russell about their experience of authoring guidelines. It covers everything you need to know about BSR guidelines- what they are, insights into the process, how to get involved (including tips for applications) and why you might like to!…

1
E111: PEXIVAS Subsets with Mike Walsh & Mats Junek 39:27

5M ago39:27

39:27

At ACR23 I had a twitter-disagreement about steroid tapers from PEXIVAS with Mike Walsh, the lead author on the PEXIVAS trial. He kindly agreed to join me for a moderated discussion. Loved hearing his perspective and have to admit he pulled me closer to his practice... but not all the way there. Longer podcast than usual but I prefer to release aud…

1
Ep 29. Cancer treatments and rheumatic disease 29:17

5M ago29:17

29:17

In this episode, Dr Mariam Malik talks to Prof Andrew Cope about cancer treatments and rheumatic disease, covering immune checkpoint inhibitors, the adverse events and rheumatological conditions they can cause, and how to manage them.由British Society for Rheumatology

1
E110: Rheum4Debate - Screening for RA-ILD with Joshua Solomon and Scott Matson 24:19

6M ago24:19

24:19

Rheum4Debate is back! In this episode I moderated a debate between two pulmonologists about RA-ILD. As a reminder, Rheum4Debate is an Oxford-style debate show, where two debators disagree over a motion during 3 rounds of discussion. The motion for todays show was: “Asymptomatic patients with rheumatoid arthritis and high risk features for interstit…

1
E109: Abatacept for Pre-RA - the ARIAA Study 16:22

6M ago16:22

16:22

Nice study this week on an important topic. Can we prevent the development of rheumatoid arthritis by initiating DMARDs during a preclinical phase? Lots to discuss: what does it mean to be "pre-clinical?" How does this fit with other studies of this nature? Check it out! https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02650-8/ful…

1
Ep 28. Writing a compelling case report 23:02

6M ago23:02

23:02

In this episode on how to write a compelling case report, Pippa Watson talks to Ai Lyn Tan, an Associate Professor and Honorary Consultant Rheumatologist at Chapel Allerton Hospital Leeds and Editor in Chief of the BSR Rheumatology Advances in Practice journal, and Caroline Groves, our Journal Development Manager at BSR. This podcast covers everyth…

1
E108: Myositis Guidelines for Cancer Screening w/Alexander Oldroyd 16:04

6M ago16:04

16:04

Informative podcast this week with Dr. Alexander Oldroyd, the first author of the recently published "International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening." The article itself appeared in Nature Reviews Rheumatology and provides what I think is a very useful framework for approaching this issue. Article: https://…

1
E107: Fragility of SLE Randomized Controlled Trials 13:17

7M ago13:17

13:17

Quick methodology episode this week discussing the concept of "fragility" in randomized controlled trials of lupus. Really enjoyed discussing this paper and was grateful to have been a part of it. Get the text here: https://lupus.bmj.com/content/lupusscimed/11/1/e001068.full.pdf由Michael Putman

1
Ep 28. NEIAA 22:46

7M ago22:46

22:46

In this episode, Sarah Gallagher talks to Dr Jo Ledingham and Dr Liz Price about all things NEIAA, from changes to data collection, findings from the 5-year report and how data can be used.由British Society for Rheumatology

1
E106: GCA/PMR with Bhaskar Dasgupta 28:28

7M ago28:28

28:28

Today I'm taking another twitter discussion into the podcast realm! Dr. Bhaskar Dasgupta has published hundreds of papers about polymyalgia rheumatica and giant cell arteritis, including a recent publication in Nature Reviews: Rheumatology that piqued my interest (https://www.nature.com/articles/s41584-023-00976-8). In this podcast we discuss scree…

1
Ep 42. Combination therapy or autologous hematopoietic stem cell transplantation for patients with progressive systemic sclerosis? 17:53

8M ago17:53

17:53

Professor Doron Rimar joins Dr Cristiana Sieiro Santos to discuss their article, which retrospectively compares the outcomes of SSc patients who underwent AHSCT to patients who met the eligibility criteria for AHSCT but received upfront combination therapy with MMF and rituximab. Listen now to hear the findings and what this means for future clinic…

1
E105: Autoimmunity Post COVID-19? 17:41

8M ago17:41

17:41

Interesting topic and interesting paper this year, including discussion of observational biases, positive and negative controls, and interpreting data as it comes. Paper: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2810259由Michael Putman

1
Ep 27. Health disparities 16:28

8M ago16:28

16:28

In this episode, we will be talking about health disparities in our Rheumatology services and how we can help tackle them at both an individual and organisational level. Prepare to be inspired. To access the free training click here (120 mins) and the published article here.由British Society for Rheumatology

1
Ep 41. Addressing the leaky pipeline 17:56

8M ago17:56

17:56

What is the leaky pipeline and how do we address it? Prof Christina Duftner (University of Innsbruck) and Prof Isabella Grabner (Vienna University of Economics and Business) join Dr Latika Gupta to discuss the diminishing proportion of women in higher ranking and leadership roles within rheumatology. Want to read more? Here's your further reading l…

1
Recent Updates on Management of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 24:01

8M ago24:01

24:01

In this podcast, clinical experts discuss key findings presented during the past year on current and emerging therapies for managing uncontrolled gout. https://cme.healio.com/mededtalks/rheumatology/20240110/3-recent-updates-on-management-of-uncontrolled-gout

1
Evidence-Based Tools to Detect and Assess Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 18:04

8M ago18:04

18:04

In this podcast, clinical experts discuss key findings presented during the past year on evidence-based tools for detection and assessment of uncontrolled gout. https://cme.healio.com/mededtalks/rheumatology/20240110/2-evidence-based-tools-to-detect-and-assess-uncontrolled-gout

1
Burden and Complications of Uncontrolled Gout, With Drs. Suneet Grewal, Puja Khanna, and Michael Pillinger 21:11

8M ago21:11

21:11

In this podcast, clinical experts discuss key findings presented during the past year on disease burden and comorbidities associated with uncontrolled gout. https://www.healio.com/cme/mededtalks/rheumatology/20240110/1-burden-and-complications-of-uncontrolled-gout

1
Ep 40. New Editor-in-Chief: Introducing Prof Ernest Choy 4:41

9M ago4:41

4:41

We're delighted to announce Prof Ernest Choy (University of Cardiff) as the incoming Editor-in-Chief of Rheumatology. In this episode, recorded at ACR23, Ernest tells us about his plans for the journal and the type of research he's keen to see. Ernest will take the reins from Dr Marwan Bukhari (Royal Lancaster Infirmary), who finishes his highly pr…

1
E104: Sarilumab for PMR - The SAPHYR Study 18:35

9M ago18:35

18:35

Important trial on the podcast this week! I take a deep dive into the recently published SAPHYR study, which evaluated the use of the IL6 inhibitor sarilumab for patients with PMR. A few aggravating quibbles but overall a very useful trial and an important step forward for patients with PMR. Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2303…

1
Ep 26. Foot pain 29:15

9M ago29:15

29:15

In this episode, Will Gregory talks to Dr Gordon Hendry about all things feet. Essential listening for all of the MDT, this podcast covers everything from the importance of examining feet to the use of ultrasound and the RADAI-F5.由British Society for Rheumatology

1
Ep 39. UK JIA Biologics Register: stopping biologics for remission 10:06

9M ago10:06

10:06

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register. Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a …

1
Ep 13. CAREERS - Paediatric rheumatology training 22:53

10M ago22:53

22:53

In this careers pod Dr Diarmuid McLaughlin talks to Dr Sharmila Jandial about training pathways for paediatric rheumatology including tips on finding out more about a career in Rheumatology, training pathways, subspecialty training and where it all can lead. Recommended for anyone thinking of getting involved.…

1
Ep 12. CAREERS - Reasons for choosing rheumatology and different career paths 28:28

10M ago28:28

28:28

In this pod aimed at medical students medical student Edward Mbanasor talks to Associate Professor Ai Lyn Tan about a career in Rheumatology covering all things from; what Rheumatology is, reasons for choosing Rheumatology, career paths and how to find out more about the specialty. A must listen for anyone considering Rheumatology as a career.…

1
Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study 7:19

10M ago7:19

7:19

Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDM…

1
E103: Len Calabrese on Monoclonal Antibodies for COVID-19 22:25

10M ago22:25

22:25

This week I took a twitter disagreement from the impersonal world of twitter to the podcast world of a back and forth conversation. Really enjoyed talking to Dr. Len Calabrese about monoclonal antibodies, FDA regulatory pathways, and life in general.由Michael Putman

1
Ep 37. Can MSUS and RADAI-F5 help to identify RA patients at risk of poor functional and radiological outcomes? 12:45

11M ago12:45

12:45

Anika Hoque joins Dr Michael Backhouse to discuss their recent article, which examines the construct validity of the RA foot disease activity index in relationship to musculoskeletal ultrasonography and clinical examination. Listen now to hear the findings, and what this means for future clinical practice and the impact on RA patients at risk for p…

1
E102: Unintentional Unblinding in Rheumatic Disease Trials 11:31

11M ago11:31

11:31

Excited to share an editorial that I wrote along with Cody Bruggemeyer and Desh Nepal, two trainees with me at the Medical College of Wisconsin. We discussed what I believe to be a pervasive (but seldom discussed) issue in rheumatology RCTs: unblinding. I suspect many of our studies suffer from this. Have a listen!…

值得一听的播客

Rheumatology播客

值得一听的播客

快速参考指南